1 - 10 of 41 articles
Key PointsQuestionAfter a grade 2 or higher immune-related adverse event, is an anti–PD-1 or anti–PD-L1 inhibitor rechallenge safe?
FindingsIn this cohort study of 93 French adults who experienced a grade 2 or higher immune-related adverse event and had an anti–PD-1 or anti–PD-L1 rechallenge,...
This review of novel oncology drugs approved by the US Food and Drug Administration examines the use of surrogate end points for overall survival, evaluates the use of patient-reported outcomes in trials supporting approvals, and seeks to determine whether drugs initially approved without...
A woman in her 80s presented with weight loss and a violaceous, cutaneous lesion of the scapula that grew from 3 cm to 30 cm in 5 months. What is your diagnosis?
This essay describes a medical physicist’s interaction with a patient and the profound effect that even the smallest patient interactions can have on health care professionals.
This study uses whole-genome sequencing to examine whether survivors of childhood lymphoma who are carriers of BRCA2 gene mutation have a greater likelihood of developing adult-onset cancers.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.